Genmab A (GMAB) Non-Current Assets (2023 - 2026)
Genmab A's Non-Current Assets came in at $9.71 billion for the quarter ended Jun 30, 2026, down 0.9% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Non-Current Assets (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Genmab A's Non-Current Assets was $9.99 billion, up 297.3% from the prior year.
- Non-Current Assets has increased in each of the last three years, with a five-year compound annual growth rate of 105.4% (years ended Dec 2020 to Dec 2025).
- Going back by year, Non-Current Assets was $2.51 billion in the year ended Dec 31, 2024 (+685.6%), $320 million in the year ended Dec 31, 2023 (+80.4%), $177.4 million in the year ended Dec 31, 2022 (-17.0%) and $213.67 million in the year ended Dec 31, 2021 (-21.8%).
- The five-year range for quarterly Non-Current Assets is $184.99 million (the quarter ended Sep 30, 2022) to $9.99 billion (the quarter ended Dec 31, 2025).
- The fastest year-over-year change in Non-Current Assets over five years came in the quarter ended Dec 31, 2024 (growth of 727.2%), and the weakest in the quarter ended Sep 30, 2021 (a decline of 88.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Genmab A | 2.56 Bn | -2.81 Bn | 1.07 Bn | 9.71 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.71 Bn |
| Mar 31, 2026 | 9.80 Bn |
| Dec 31, 2025 | 9.99 Bn |
| Sep 30, 2025 | 2.55 Bn |
| Jun 30, 2025 | 2.55 Bn |
| Mar 31, 2025 | 2.55 Bn |
| Dec 31, 2024 | 2.51 Bn |
| Sep 30, 2024 | 2.40 Bn |
| Mar 31, 2024 | 335.00 Mn |
| Dec 31, 2023 | 320.00 Mn |
| Jan 1, 2023 | 273.00 Mn |
API Access
Genmab A Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();